company background image
BTMD logo

biote NasdaqGM:BTMD Stock Report

Last Price

US$6.18

Market Cap

US$230.7m

7D

-7.3%

1Y

22.4%

Updated

18 Dec, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

biote Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for biote
Historical stock prices
Current Share PriceUS$6.18
52 Week HighUS$8.44
52 Week LowUS$3.65
Beta1.07
1 Month Change0.32%
3 Month Change1.15%
1 Year Change22.38%
3 Year Change-37.00%
5 Year Changen/a
Change since IPO-38.51%

Recent News & Updates

biote Corp. (NASDAQ:BTMD) Soars 26% But It's A Story Of Risk Vs Reward

Dec 02
biote Corp. (NASDAQ:BTMD) Soars 26% But It's A Story Of Risk Vs Reward

Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

Sep 27
Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

Recent updates

biote Corp. (NASDAQ:BTMD) Soars 26% But It's A Story Of Risk Vs Reward

Dec 02
biote Corp. (NASDAQ:BTMD) Soars 26% But It's A Story Of Risk Vs Reward

Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

Sep 27
Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

biote initiated as a buy at Truist on leadership in hormone optimization; sees 138% upside

Sep 27

Biote partners with IMAC Holdings

Sep 07

Shareholder Returns

BTMDUS PharmaceuticalsUS Market
7D-7.3%-1.4%0.1%
1Y22.4%9.2%26.1%

Return vs Industry: BTMD exceeded the US Pharmaceuticals industry which returned 9.2% over the past year.

Return vs Market: BTMD underperformed the US Market which returned 26.1% over the past year.

Price Volatility

Is BTMD's price volatile compared to industry and market?
BTMD volatility
BTMD Average Weekly Movement10.7%
Pharmaceuticals Industry Average Movement10.3%
Market Average Movement6.3%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: BTMD's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: BTMD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2012194Terry Weberbiote.com

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.

biote Corp. Fundamentals Summary

How do biote's earnings and revenue compare to its market cap?
BTMD fundamental statistics
Market capUS$230.72m
Earnings (TTM)US$7.19m
Revenue (TTM)US$193.06m

26.7x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BTMD income statement (TTM)
RevenueUS$193.06m
Cost of RevenueUS$57.83m
Gross ProfitUS$135.23m
Other ExpensesUS$128.04m
EarningsUS$7.19m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.23
Gross Margin70.05%
Net Profit Margin3.72%
Debt/Equity Ratio-93.7%

How did BTMD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 23:49
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

biote Corp. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey Van SinderenB. Riley Securities, Inc.
Alex FuhrmanCraig-Hallum Capital Group LLC
Kaumil GajrawalaJefferies LLC